|
1
|
Schwartzbaum JA, Fisher JL, Aldape KD and
Wrensch M: Epidemiology and molecular pathology of glioma. Nat Clin
Pract Neurol. 2:494–503; quiz 1 p following 516. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar
|
|
3
|
Minniti G, Muni R, Lanzetta G, Marchetti P
and Enrici RM: Chemotherapy for glioblastoma: current treatment and
future perspectives for cytotoxic and targeted agents. Anticancer
Res. 29:5171–5184. 2009.PubMed/NCBI
|
|
4
|
Cairncross G, Macdonald D, Ludwin S, et
al: Chemotherapy for anaplastic oligodendroglioma. National Cancer
Institute of Canada Clinical Trials. Group J Clin Oncol.
12:2013–2021. 1994.PubMed/NCBI
|
|
5
|
Yung WK, Prados MD, Yaya-Tur R, et al:
Multicenter phase II trial of temozolomide in patients with
anaplastic astrocytoma or anaplastic oligoastrocytoma at first
relapse. Temodal Brain Tumor. Group J Clin Oncol. 17:2762–2771.
1999.PubMed/NCBI
|
|
6
|
Stupp R, Hegi ME, Mason WP, et al: Effects
of radiotherapy with concomitant and adjuvant temozolomide versus
radiotherapy alone on survival in glioblastoma in a randomised
phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet
Oncol. 10:459–466. 2009.
|
|
7
|
Stewart LA: Chemotherapy in adult
high-grade glioma: a systematic review and meta-analysis of
individual patient data from 12 randomised trials. Lancet.
359:1011–1018. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Stupp R, Mason WP, van den Bent MJ, et al:
Radiotherapy plus concomitant and adjuvant temozolomide for
glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hart MG, Grant R, Garside R, Rogers G,
Somerville M and Stein K: Chemotherapy wafers for high grade
glioma. Cochrane Database Syst Rev CD. 0072942011.PubMed/NCBI
|
|
10
|
Friedman HS, Prados MD, Wen PY, et al:
Bevacizumab alone and in combination with irinotecan in recurrent
glioblastoma. J Clin Oncol. 27:4733–4740. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tianjin Medical School Affliated Hospital:
Preliminary study on BCNU in the treatment of intracranial tumors:
report of 45 cases. Tianjin Med J. 15:26–28. 1973.(In Chinese).
|
|
12
|
The First Affliated Hospital to Suzhou
Medical School: Preliminary observation of treating gliomas in
central nervous system with CCNU. Chin J Nerv Ment Dis. 1:51–53.
1975.(In Chinese).
|
|
13
|
Zeng X and Yang S: Clinical observation in
chemotherapy with temozolomide alone in postoperative malignant
primary cerebral glioma. Mod J Neurol Neurosurg. 3:270–273.
2003.
|
|
14
|
Newton HB: Intra-arterial chemotherapy of
primary brain tumors. Curr Treat Options Oncol. 6:519–530. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tyler JL, Yamamoto YL, Diksic M, et al:
Pharmacokinetics of superselective intra-arterial and intravenous
[11C]BCNU evaluated by PET. J Nucl Med. 27:775–780. 1986.PubMed/NCBI
|
|
16
|
Shapiro WR, Green SB, Burger PC, et al: A
randomized comparison of intra-arterial versus intravenous BCNU,
with or without intravenous 5-fluorouracil, for newly diagnosed
patients with malignant glioma. J Neurosurg. 76:772–781. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Westphal M, Hilt DC, Bortey E, et al: A
phase 3 trial of local chemotherapy with biodegradable carmustine
(BCNU) wafers (Gliadel wafers) in patients with primary malignant
glioma. Neuro Oncol. 5:79–88. 2003.PubMed/NCBI
|
|
18
|
Lin Y, Chen W, Zhuge Q, et al: Combined
CT-guided stereo-tactic interstitial radiotherapy of 32P and MTX
chemotherapy for treatment of deep brain gliomas. Chin J Neurosurg.
12:216–218. 1996.(In Chinese).
|
|
19
|
Qi S and Qiu B: Treatment of recurrent
malignant brain gliomas by surgical excision combined with
biodegradable polymers of interstitial chemotherapy. Zhonghua Zhong
Liu Za Zhi. 26:58–61. 2004.(In Chinese).
|
|
20
|
Li A, Zhang X, Yi Y, et al: Interstitial
chemotherapy for malignant chemotherapy. Chin J Clin Neurosurg.
4:24–26. 1999.(In Chinese).
|
|
21
|
Buckner JC: Factors influencing survival
in high-grade gliomas. Semin Oncol. 30:10–14. 2003. View Article : Google Scholar
|
|
22
|
Van Meir EG, Hadjipanayis CG, Norden AD,
Shu HK, Wen PY and Olson JJ: Exciting new advances in
neuro-oncology: the avenue to a cure for malignant glioma. CA
Cancer J Clin. 60:166–193. 2010.PubMed/NCBI
|
